BackTable Vascular & Interventional
Ep. 480 Venous Treatments: How Low Do You Go? with Dr. Adam Raskin
Sep 17, 2024
Dr. Adam Raskin, an interventional cardiologist and medical director at Mercy Health in Cincinnati, dives into the latest advancements in DVT and PE treatments. He emphasizes the need for more randomized trials to refine venous disease guidelines. The discussion highlights innovative thrombectomy systems, the importance of accurate diagnostics, and improved follow-up care to enhance patient outcomes. Raskin also shares insights on future trends in venous interventions, showcasing the evolution of endovascular therapy.
46:28
Episode guests
AI Summary
AI Chapters
Episode notes
Podcast summary created with Snipd AI
Quick takeaways
- The podcast emphasizes the growing reliance on data-driven practices and the need for randomized trials to improve DVT treatment protocols.
- Effective management of DVT patients relies on creating a streamlined referral network and aggressive intervention strategies, particularly for those with pulmonary embolism.
Deep dives
Emphasis on Data and Innovation in DVT Treatment
There is a growing excitement among interventional cardiologists regarding the collection and utilization of data to improve deep vein thrombosis (DVT) treatment. The discussion highlights how more operators are becoming engaged in enrolling patients in clinical trials and actively participating in research initiatives. This shift toward data-driven practices is expected to lead to significant advancements in the understanding of DVT management, ultimately changing treatment protocols. The speaker expresses optimism about the potential for randomized trials to clarify best practices and establish new care guidelines.
Remember Everything You Learn from Podcasts
Save insights instantly, chat with episodes, and build lasting knowledge - all powered by AI.
